Literature DB >> 22706869

Developmental differences in megakaryocyte size in infants and children.

Deborah A Fuchs1, Sarah G McGinn, Carlos L Cantu, Robert R Klein, Martha C Sola-Visner, Lisa M Rimsza.   

Abstract

Developmental differences in megakaryocytes between neonates and adults have been described. However, the age at which megakaryocytes make a transition to an adult phenotype is unknown. Small megakaryocytes are often described as "dysplastic" in the pathology literature. Thus, recognizing the normal features of megakaryocytes at different ages has diagnostic implications. We identified 72 samples from 61 patients, aged 3 days to 80 years, who had negative staging based on bone marrow examination. Megakaryocyte diameters, as highlighted with anti-CD61, were measured. A scatter plot of megakaryocyte size by age revealed a normal distribution of sizes at the youngest ages, with a shift to multiple peaks starting at 24 months indicating that neonates have megakaryocytes of uniform sizes, which diverge into separate clusters of smaller and larger cells beginning at 2 years; this is followed by an overall shift toward larger megakaryocytes at age 4 years. These observations have direct implications for the evaluation of bone marrow megakaryocytes in young children.

Entities:  

Mesh:

Year:  2012        PMID: 22706869     DOI: 10.1309/AJCP4EMTJYA0VGYE

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Lin28b regulates age-dependent differences in murine platelet function.

Authors:  Massiel Chavez Stolla; Seana C Catherman; Paul D Kingsley; R Grant Rowe; Anne D Koniski; Katherine Fegan; Leah Vit; Kathleen E McGrath; George Q Daley; James Palis
Journal:  Blood Adv       Date:  2019-01-08

2.  Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition.

Authors:  Kamaleldin E Elagib; Chih-Huan Lu; Goar Mosoyan; Shadi Khalil; Ewelina Zasadzińska; Daniel R Foltz; Peter Balogh; Alejandro A Gru; Deborah A Fuchs; Lisa M Rimsza; Els Verhoeyen; Miriam Sansó; Robert P Fisher; Camelia Iancu-Rubin; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

Review 3.  Megakaryocyte ontogeny: Clinical and molecular significance.

Authors:  Kamaleldin E Elagib; Ashton T Brock; Adam N Goldfarb
Journal:  Exp Hematol       Date:  2018-03-02       Impact factor: 3.084

4.  Developmental differences between newborn and adult mice in response to romiplostim.

Authors:  Katherine A Sparger; Haley Ramsey; Viola Lorenz; Zhi-Jian Liu; Henry A Feldman; Nan Li; Tahirih Laforest; Martha C Sola-Visner
Journal:  Platelets       Date:  2017-05-26       Impact factor: 3.862

Review 5.  Changes in megakaryopoiesis over ontogeny and their implications in health and disease.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Platelets       Date:  2020-03-21       Impact factor: 3.862

6.  Fetal vs adult megakaryopoiesis.

Authors:  Patricia Davenport; Zhi-Jian Liu; Martha Sola-Visner
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

Review 7.  Manipulating megakaryocytes to manufacture platelets ex vivo.

Authors:  P Karagiannis; K Eto
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

8.  Identification of a potent small molecule capable of regulating polyploidization, megakaryocyte maturation, and platelet production.

Authors:  Nick Huang; Mabel Lou; Hua Liu; Cecilia Avila; Yupo Ma
Journal:  J Hematol Oncol       Date:  2016-12-08       Impact factor: 17.388

Review 9.  Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade.

Authors:  Daniel O'Reilly; Claire A Murphy; Richard Drew; Afif El-Khuffash; Patricia B Maguire; Fionnuala Ni Ainle; Naomi Mc Callion
Journal:  Pediatr Res       Date:  2021-10-28       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.